Details

Autor(en) / Beteiligte

• LaFavers, Kaice A
• Hage, Chadi A
• Gaur, Varun
• Micanovic, Radmila
• Hato, Takashi
• Khan, Shehnaz
• Winfree, Seth
• Doshi, Simit
• Moorthi, Ranjani N
• Twigg, Homer
• Wu, Xue-Ru
• Dagher, Pierre C
• Srour, Edward F
• El-Achkar, Tarek M

Titel

The kidney protects against sepsis by producing systemic uromodulin

Ist Teil von

• American journal of physiology. Renal physiology, 2022-08, Vol.323 (2), p.F212-F226

Ort / Verlag

United States: American Physiological Society

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Sepsis is a significant cause of mortality in hospitalized patients. Concomitant development of acute kidney injury (AKI) increases sepsis mortality through unclear mechanisms. Although electrolyte disturbances and toxic metabolite buildup during AKI could be important, it is possible that the kidney produces a protective molecule lost during sepsis with AKI. We have previously demonstrated that systemic Tamm-Horsfall protein (THP; uromodulin), a kidney-derived protein with immunomodulatory properties, falls in AKI. Using a mouse sepsis model without severe kidney injury, we showed that the kidney increases circulating THP by enhancing the basolateral release of THP from medullary thick ascending limb cells. In patients with sepsis, changes in circulating THP were positively associated with a critical illness. THP was also found de novo in injured lungs. Genetic ablation of THP in mice led to increased mortality and bacterial burden during sepsis. Consistent with the increased bacterial burden, the presence of THP in vitro and in vivo led macrophages and monocytes to upregulate a transcriptional program promoting cell migration, phagocytosis, and chemotaxis, and treatment of macrophages with purified THP increases phagocytosis. Rescue of septic mice with exogenous systemic THP improved survival. Together, these findings suggest that through releasing THP, the kidney modulates the immune response in sepsis by enhancing mononuclear phagocyte function, and systemic THP has therapeutic potential in sepsis. Specific therapies to improve outcomes in sepsis with kidney injury have been limited by an unclear understanding of how kidney injury increases sepsis mortality. Here, we identified Tamm-Horsfall protein, known to protect in ischemic acute kidney injury, as protective in preclinical sepsis models. Tamm-Horsfall protein also increased in clinical sepsis without severe kidney injury and concentrated in injured organs. Further study could lead to novel sepsis therapeutics.